A multicenter, randomized, phase II study evaluating the efficacy and safety of combination docetaxel and carboplatin and sequential therapy with docetaxel then carboplatin in patients with recurrent platinum-sensitive ovarian cancer
Publication
, Journal Article
Alvarez-Secord, A; Berchuck, A; Higgins, R; Nycum, L; Kohler, M; Puls, L; Holloway, R; Lewandowski, G; Valea, F; Havrilesky, L
Published in: GYNECOLOGIC ONCOLOGY
March 1, 2010
Duke Scholars
Published In
GYNECOLOGIC ONCOLOGY
ISSN
0090-8258
Publication Date
March 1, 2010
Volume
116
Issue
3
Start / End Page
S3 / S3
Publisher
ACADEMIC PRESS INC ELSEVIER SCIENCE
Related Subject Headings
- Oncology & Carcinogenesis
- 3215 Reproductive medicine
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences
- 1114 Paediatrics and Reproductive Medicine
- 1112 Oncology and Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Alvarez-Secord, A., Berchuck, A., Higgins, R., Nycum, L., Kohler, M., Puls, L., … Havrilesky, L. (2010). A multicenter, randomized, phase II study evaluating the efficacy and safety of combination docetaxel and carboplatin and sequential therapy with docetaxel then carboplatin in patients with recurrent platinum-sensitive ovarian cancer. GYNECOLOGIC ONCOLOGY, 116(3), S3–S3.
Alvarez-Secord, A., A. Berchuck, R. Higgins, L. Nycum, M. Kohler, L. Puls, R. Holloway, G. Lewandowski, F. Valea, and L. Havrilesky. “A multicenter, randomized, phase II study evaluating the efficacy and safety of combination docetaxel and carboplatin and sequential therapy with docetaxel then carboplatin in patients with recurrent platinum-sensitive ovarian cancer.” GYNECOLOGIC ONCOLOGY 116, no. 3 (March 1, 2010): S3–S3.
Alvarez-Secord A, Berchuck A, Higgins R, Nycum L, Kohler M, Puls L, et al. A multicenter, randomized, phase II study evaluating the efficacy and safety of combination docetaxel and carboplatin and sequential therapy with docetaxel then carboplatin in patients with recurrent platinum-sensitive ovarian cancer. GYNECOLOGIC ONCOLOGY. 2010 Mar 1;116(3):S3–S3.
Alvarez-Secord, A., et al. “A multicenter, randomized, phase II study evaluating the efficacy and safety of combination docetaxel and carboplatin and sequential therapy with docetaxel then carboplatin in patients with recurrent platinum-sensitive ovarian cancer.” GYNECOLOGIC ONCOLOGY, vol. 116, no. 3, ACADEMIC PRESS INC ELSEVIER SCIENCE, Mar. 2010, pp. S3–S3.
Alvarez-Secord A, Berchuck A, Higgins R, Nycum L, Kohler M, Puls L, Holloway R, Lewandowski G, Valea F, Havrilesky L. A multicenter, randomized, phase II study evaluating the efficacy and safety of combination docetaxel and carboplatin and sequential therapy with docetaxel then carboplatin in patients with recurrent platinum-sensitive ovarian cancer. GYNECOLOGIC ONCOLOGY. ACADEMIC PRESS INC ELSEVIER SCIENCE; 2010 Mar 1;116(3):S3–S3.
Published In
GYNECOLOGIC ONCOLOGY
ISSN
0090-8258
Publication Date
March 1, 2010
Volume
116
Issue
3
Start / End Page
S3 / S3
Publisher
ACADEMIC PRESS INC ELSEVIER SCIENCE
Related Subject Headings
- Oncology & Carcinogenesis
- 3215 Reproductive medicine
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences
- 1114 Paediatrics and Reproductive Medicine
- 1112 Oncology and Carcinogenesis